CoreAge Rx vs Cielo
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Cielo head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Cielo a bad call — it's best for readers comparing advertised monthly plans with longer commitments who can obtain a complete patient agreement first. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Cielo |
|---|---|---|
| Brief Score | 94/100 (A) | 69/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm promotional terms Flash-sale $139/mo versus displayed regular $199; actual renewal charge unconfirmed. The $84 equivalent requires 12 months with full payment unconfirmed. Full price detailsCompounded semaglutide offered; complete current renewal quote unknown; flash-sale monthly offer $139 versus displayed regular $199; $84 equivalent requires 12 months with full charge unconfirmed; earlier listing: From $149/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm promotional terms Flash-sale $189/mo versus displayed regular $299; actual renewal charge unconfirmed. The $119 equivalent requires 12 months with full payment unconfirmed. Full price detailsCompounded tirzepatide offered; complete current renewal quote unknown; flash-sale monthly offer $189 versus displayed regular $299; $119 equivalent requires 12 months with full charge unconfirmed; earlier listing: From $249/mo (all doses, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Confirm medication-specific clinician and pharmacy access; a complete current state roster was not established |
| Brand-name access | Not confirmed | Current branded-medication program unconfirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Cielo: Flash-sale monthly offers show $139 semaglutide/$189 tirzepatide; renewal prices and full longer-plan charges remain unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.